ATE367807T1 - Thioharnstoff-enthaltendes arzneimitel zur verwendung als depigmentierungsmittel oder als antimutagen und antikarzinogen - Google Patents

Thioharnstoff-enthaltendes arzneimitel zur verwendung als depigmentierungsmittel oder als antimutagen und antikarzinogen

Info

Publication number
ATE367807T1
ATE367807T1 AT03776954T AT03776954T ATE367807T1 AT E367807 T1 ATE367807 T1 AT E367807T1 AT 03776954 T AT03776954 T AT 03776954T AT 03776954 T AT03776954 T AT 03776954T AT E367807 T1 ATE367807 T1 AT E367807T1
Authority
AT
Austria
Prior art keywords
anticarcinogene
depigmentant
antimutagen
medicinal product
containing medicinal
Prior art date
Application number
AT03776954T
Other languages
English (en)
Inventor
Daniel Jean
Cherif Rabhi
Original Assignee
Lmd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lmd filed Critical Lmd
Application granted granted Critical
Publication of ATE367807T1 publication Critical patent/ATE367807T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Birds (AREA)
  • Neurology (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03776954T 2002-10-11 2003-10-03 Thioharnstoff-enthaltendes arzneimitel zur verwendung als depigmentierungsmittel oder als antimutagen und antikarzinogen ATE367807T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0212697A FR2845599B1 (fr) 2002-10-11 2002-10-11 Medicament comprenant une thiouree pour son utilisation en tant que depigmentant

Publications (1)

Publication Number Publication Date
ATE367807T1 true ATE367807T1 (de) 2007-08-15

Family

ID=32039668

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03776954T ATE367807T1 (de) 2002-10-11 2003-10-03 Thioharnstoff-enthaltendes arzneimitel zur verwendung als depigmentierungsmittel oder als antimutagen und antikarzinogen

Country Status (12)

Country Link
US (1) US20060135618A1 (de)
EP (1) EP1553933B1 (de)
JP (1) JP2006509733A (de)
KR (1) KR20050094806A (de)
AT (1) ATE367807T1 (de)
AU (1) AU2003286213A1 (de)
CA (1) CA2501742A1 (de)
DE (1) DE60315176D1 (de)
FR (1) FR2845599B1 (de)
MX (1) MXPA05003891A (de)
NO (1) NO20052176L (de)
WO (1) WO2004032912A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2881654B1 (fr) * 2005-02-07 2009-05-29 Lmd Compositions medicinales contenant une alkylsulfone pour le traitement du cancer en association a des agents chimiotherapeutiques ou a des rayonnements ionisants ou non ionisants
WO2007039821A2 (en) * 2005-08-31 2007-04-12 Galderma Research & Development Novel inhibitors of tyrosinase, their method of preparation and their use in human medicine and in cosmetics
FR2890070A1 (fr) * 2005-08-31 2007-03-02 Galderma Res & Dev Nouveaux inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
WO2008015315A1 (fr) * 2006-08-03 2008-02-07 Lmd Compositions medicinales contenant une thiouree pour le traitement du cancer en association avec des agents chimiotherapeutiques ou des rayonnements ionisants ou non ionisants
EP2440198B1 (de) * 2009-06-09 2016-01-06 Cimas Limited Halogenierte aliphatische carbonsäuren, oligomere und/oder polymere daraus und ihre verwendung bei der devitalisierung externer und interner neoplasmen
BE1019432A3 (fr) * 2010-07-23 2012-07-03 Auriga Internat Utilisation d'isothiocyanates et derives pour le traitement et/ou la prevention des lucites.
BE1019431A3 (fr) * 2010-07-23 2012-07-03 Auriga Internat Procede de synthese d'isothiocyanates et leurs derives et utilisations de ceux-ci.
CA2875063C (en) 2012-06-01 2021-01-12 Pharmagra Labs, Inc. Method of synthesising sulforaphane
TWI508950B (zh) * 2014-08-29 2015-11-21 Univ Hungkuang 3-methyl-2-sulfanyl-2,3-dihydro-1H-imidazole-1-carboxylic acid Tertiary butyl ester and its preparation method and use
WO2018046243A1 (en) 2016-09-06 2018-03-15 Unilever N.V. Compounds for reducing cellular melanin content
KR102201385B1 (ko) * 2018-10-11 2021-01-11 주식회사 그라젬 피부 미백용 조성물 및 이를 이용한 미백용 화장품

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411986A (en) * 1993-03-12 1995-05-02 The Johns Hopkins University Chemoprotective isothiocyanates
US20020044914A1 (en) * 2000-02-29 2002-04-18 Dooley Thomas P. Inhibitors of melanocyte tyrosinase as topical skin lighteners
FR2820036B1 (fr) * 2001-01-26 2005-12-09 L M D Utilisation d'un isothiocyanate, d'un thiocyanate ou de leur melange en tant que depigmentant

Also Published As

Publication number Publication date
EP1553933B1 (de) 2007-07-25
WO2004032912A1 (fr) 2004-04-22
MXPA05003891A (es) 2005-08-03
JP2006509733A (ja) 2006-03-23
CA2501742A1 (fr) 2004-04-22
DE60315176D1 (de) 2007-09-06
AU2003286213A1 (en) 2004-05-04
FR2845599A1 (fr) 2004-04-16
KR20050094806A (ko) 2005-09-28
FR2845599B1 (fr) 2005-01-07
NO20052176L (no) 2005-05-03
EP1553933A1 (de) 2005-07-20
US20060135618A1 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
NO20051209L (no) Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk anvendelse derav samt intermediater for samme
BRPI0412219B8 (pt) compostos ômega-carboxi aril difenil uréia fluoro substituídos e composições farmacêuticas compreendendo os referidos compostos
DE60013250D1 (en) Phenylharnstoffe und phenylthioharnstoffe als orexinrezeptorantagonisten
HUP0302451A2 (hu) (Tio)karbamoil-ciklohexán származékok, eljárás előállításukra és ezeket hatóanyagként tartalmazó gyógyszerkészítmények
BR0311952A (pt) Novos compostos úteis para o tratamento de obesidade, diabetes tipo ii e distúrbios do snc
BR0013667A (pt) Derivados de glucopiranosiloxipirazol, composições medicinais contendo os mesmos derivados e seus intermediários na produção dos mesmos
DE60315176D1 (de) Thioharnstoff-enthaltendes arzneimitel zur verwendung als depigmentierungsmittel oder als antimutagen und antikarzinogen
EP1424330A4 (de) Aktivator für den peroxisome proliferator-responsiven rezeptor delta
AR032466A1 (es) Ciclilamina sulfonamidas, utilizacion de las mismas para la manufactura de un medicamento y composiciones farmaceuticas utiles como agonistas de los receptores beta-3 adrenergicos
ATE548032T1 (de) Verwendung von chlorguanabenzderivaten zur behandlung von mit polyglutaminexpansion assoziierten erkrankungen
DE60011462D1 (de) Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung
TR200103349T2 (tr) Purin türevleri, hazırlama usulü ve bunları içeren ispençiyari bileşimleri.
AR046705A1 (es) Pirido-7-pirimidin-7-onas substituidas con hidroxialquilo
IL153395A0 (en) Vitamin d derivatives
BR0209650A (pt) Análogos de adenosina para o tratamento da sìndrome de resistência à insulina e da diabetes
ATE420853T1 (de) 5-amidino-2-hydroxybenzolsulfonamidderivate, pharmazeutischen zusammensetzungen, die diese verbindungen enthalten, und zwischenprodukte zu deren herstellung
SE8300855L (sv) Nya piperazin- och homopiperazinderivat, forfaranden for framstellning derav och farmaceutiska kompositioner innehallande dem
BR9809643A (pt) Compostos heterocìclicos, seu processo de preparo e as composições farmacêuticas que os contêm
DE602004019778D1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
ITMI20031144A1 (it) Analoghi del colchicoside.
IL122247A0 (en) Use of sulfamic acid derivatives acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels
DE502005003310D1 (de) Cycloalkyl substituierte 7-amino-4-chinolon-3-carbonsäure-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE118346T1 (de) Verwendung von bis(4-hydroxyphenylthio)methan- derivaten zur behandlung von diabetes mellitus.
DE3872425D1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
DE69920524T8 (de) Verfahren zur herstellung von n,n&#39;-disubstituiertem-3,3&#39;-dithiodipropionamid und verfahren zur herstellung von substituierten 3-isothiazolon durch verwendung desselben

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties